Short answer
CVS Health (CVS) filed an 8-K current report with the SEC on August 5, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). CVS Health’s filing contains only signature and cover-page information.
CVS Health 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- CVS Health’s filing contains only signature and cover-page information
- No results, financial figures, reporting period, or earnings-release details included in the provided text
Item EX-99.1 · Exhibit EX-99.1
- Q2 revenue $106.1B, up 7.3%, with adjusted EPS $2.58 versus $1.81 year over year
- Full-year adjusted EPS guidance raised to $7.90-$8.10 from $7.30-$7.50
- Operating momentum broad-based, led by Health Care Benefits adjusted operating income up 85.5% to $2.426B
- Health Care Benefits MBR improved to 87.4% from 89.9%, supporting margin-recovery credibility
- Operating cash flow guidance raised to at least $11.5B from $9.5B, with $10.6B generated year to date
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other CVS Health 8-K filings
Get the next CVS 8-K as it lands
Follow CVS for push alerts, or ask the research agent what this filing means.